MC12
Product Specifications
Target
SARS-CoV, Virus Protease
Related Pathways
Microbiology/Virology
Bioactivity
MC12 is a thiazole derivative and an inhibitor of SARS-CoV-2 main protease (IC50: 77.7 nM) . It effectively inhibits the main protease of both SARS-CoV and SARS-CoV-2, with low cytotoxicity and good stability. MC12 is suitable for research in anti-COVID-19 drug development.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1166098-01 0.02 mg (E-Coli)
Recombinant Coxiella burnetii Pantothenate synthetase (panC)
Sign In for Pricing
View Details MBS1166098-02 0.1 mg (E-Coli)
Recombinant Coxiella burnetii Pantothenate synthetase (panC)
Sign In for Pricing
View Details MBS1166098-03 0.02 mg (Yeast)
Recombinant Coxiella burnetii Pantothenate synthetase (panC)
Sign In for Pricing
View Details MBS1166098-04 0.1 mg (Yeast)
Recombinant Coxiella burnetii Pantothenate synthetase (panC)
Sign In for Pricing
View Details MBS1166098-05 0.02 mg (Baculovirus)
Recombinant Coxiella burnetii Pantothenate synthetase (panC)
Sign In for Pricing
View Details MBS1166098-06 0.02 mg (Mammalian-Cell)
Recombinant Coxiella burnetii Pantothenate synthetase (panC)
Sign In for Pricing
View Details